Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05316584 · ClinicalTrials.gov registry record · NA
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
A NA study of Ulcerative Colitis and Crohn Disease, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 5
- Study locations
NCT05316584 is a NA study of Ulcerative Colitis and Crohn Disease that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 123 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT05316584, a NA study of Ulcerative Colitis and Crohn Disease, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigators hypothesize that use of a remote monitoring digital health system that supports medication taking and monitoring of symptoms will improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease initiating oral or subcutaneous treatment. The investigators are conducting a 12-month, multicenter, randomized, controlled trial to assess the feasibility and effectiveness of a remote monitoring digital health system on adherence, clinical outcomes, and healthcare utilization. The investigators will address the following specific aims: 1. Compare adherence as measured by the medication possession ratio in participants using a remote monitoring digital health system compared to standard of care. 2. Compare clinical outcomes and healthcare utilization in participants using a remote monitoring digital health system compared to standard of care.
Conditions Studied
Interventions
- BEHAVIORAL Remote monitoring
Study Locations (5)
Maryland
- University of Maryland School of Medicine - Baltimore
New York
- New York University - New York
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05316584
The ClinicalTrials.gov registry entry for NCT05316584 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Remote monitoring is the first listed.
NCT05316584 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Maryland, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05316584 about?
NCT05316584 is a clinical study titled "A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy". The investigators hypothesize that use of a remote monitoring digital health system that supports medication taking and monitoring of symptoms will improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease init...
What is the current status of trial NCT05316584?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2022-09-06. Estimated completion is 2026-03-31.
What conditions does trial NCT05316584 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases.
What interventions are being tested in trial NCT05316584?
The interventions under investigation include: Remote monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05316584?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05316584 being conducted?
This trial has 5 study locations across Maryland, New York, North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.